BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25194144)

  • 1. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration.
    Franch-Nadal J; Roura-Olmeda P; Benito-Badorrey B; Rodriguez-Poncelas A; Coll-de-Tuero G; Mata-Cases M;
    Fam Pract; 2015 Feb; 32(1):27-34. PubMed ID: 25194144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study.
    Mwita JC; Francis JM; Omech B; Botsile E; Oyewo A; Mokgwathi M; Molefe-Baikai OJ; Godman B; Tshikuka JG
    BMJ Open; 2019 Jul; 9(7):e026807. PubMed ID: 31340960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
    Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
    Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of poor glycaemic control in older patients with type 2 diabetes mellitus.
    Sazlina SG; Mastura I; Cheong AT; Bujang Mohamad A; Jamaiyah H; Lee PY; Syed Alwi SA; Chew BH
    Singapore Med J; 2015 May; 56(5):284-90. PubMed ID: 25814074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors associated with the optimum simultaneous control of diabetes, arterial hypertension and hypercholesterolemia in the diabetic population. BPC Diabetes study].
    Llisterri-Caro JL; Turégano-Yedro M; Cinza-Sanjurjo S; Segura-Fragoso A; Sánchez-Sánchez B; Cubelos-Fernández N; Velilla-Zancada S; Micó-Pérez RM; Martín-Sánchez V;
    Semergen; 2022; 48(4):225-234. PubMed ID: 34479796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
    Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
    BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?
    Reddy SV; Bhatia E
    Natl Med J India; 2011; 24(1):21-7. PubMed ID: 21608354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus.
    Göbl CS; Brannath W; Bozkurt L; Handisurya A; Anderwald C; Luger A; Krebs M; Kautzky-Willer A; Bischof MG
    Gend Med; 2010 Dec; 7(6):593-9. PubMed ID: 21195359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study.
    Valenzuela-Garcia LF; Matsuzawa Y; Sara JD; Kwon TG; Lennon RJ; Lerman LO; Ruiz-Salmeron RJ; Lerman A
    Cardiovasc Diabetol; 2015 Aug; 14():106. PubMed ID: 26268857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia.
    Mengual L; Roura P; Serra M; Montasell M; Prieto G; Bonet S
    Cardiovasc Diabetol; 2010 Mar; 9():14. PubMed ID: 20350315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes.
    Swoboda PP; Erhayiem B; Kan R; McDiarmid AK; Garg P; Musa TA; Dobson LE; Witte KK; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S
    Cardiovasc Diabetol; 2018 Mar; 17(1):35. PubMed ID: 29506523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing optimal diabetes care and clinical outcomes in Thai patients with type 2 diabetes mellitus: a multilevel modelling analysis.
    Surawit A; Pongkunakorn T; Manosan T; Mongkolsucharitkul P; Chamnan P; Suvarnabhumi K; Puangpet T; Suta S; Pumeiam S; Pinsawas B; Ophakas S; Pisitpornsuk S; Utchin C; Mayurasakorn K
    BMJ Open; 2024 May; 14(5):e079415. PubMed ID: 38702083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between glycaemic control and lipid profile in type 2 diabetes mellitus patients in a low-resource setting.
    Nnakenyi ID; Nnakenyi EF; Parker EJ; Uchendu NO; Anaduaka EG; Ezeanyika LU
    Pan Afr Med J; 2022; 41():281. PubMed ID: 35855025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.